This finding was confirmed in 1993, the same year that specific germline mutations of the RET gene were found in families with MEN 2A, which definitively established the association of RET point mutations on chromosome 10q11.2 with the development of medullary thyroid cancer [32,56,57]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.